Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.54 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.54 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29430856 | 1.00 | GABRA1 (0.54) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL16379272 | 0.85 | GABRA1 (0.50) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL29468969 | 0.85 | ENPP2 (0.41) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL12640622 | 0.85 | ENPP2 (0.41) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL2247879 | 0.82 | ENPP2 (0.43) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL24478328 | 0.81 | GABRA1 (0.48) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL4652041 | 0.81 | GABRA1 (0.48) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL28105050 | 0.81 | GABRA1 (0.67) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL29951757 | 0.80 | ENPP2 (0.41) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL4013443 | 0.80 | ENPP2 (0.41) | GABRA1GABRB2GABRG2GABRB3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111171721-B | Ceramizable ablation-resistant coating and preparation method thereof | 西安近代化学研究所 | 2021-08-20 | — | — | CN | claimed |
| CN-111171721-A | Ceramizable ablation-resistant coating and preparation method thereof | 西安近代化学研究所 | 2020-05-19 | — | — | CN | claimed |
| CN-109467662-A | A kind of RTM type boron bakelite resin and preparation method thereof | 北京玻钢院复合材料有限公司 | 2019-03-15 | — | — | CN | claimed |
| CN-109456571-A | A kind of heat molten type boron bakelite resin and preparation method thereof | 北京玻钢院复合材料有限公司 | 2019-03-12 | — | — | CN | claimed |
| CN-105086351-B | A kind of hot melt phenolic resin preimpregnation material and preparation method thereof | 西安交通大学 | 2018-07-17 | — | — | CN | claimed |
| CN-105086351-A | Hot-melting phenolic resin prepreg and preparation method thereof | UNIV XI AN JIAOTONG | 2015-11-25 | — | — | CN | claimed |
| CN-103289033-B | Containing aryl boron bakelite resin and preparation method thereof | XI'AN JIAOTONG UNIVERSITY (CN) | 2015-10-28 | — | — | CN | claimed |
| CN-122079945-A | Coumarin derivative containing substituted phenyl ether structure, preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122059933-A | Pyrazolo [4,3-d ] pyrimidinone derivative and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2026-05-19 | — | — | CN | disclosed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-12616682-B2 | 1-H-pyrrolo[2,3-c]pyridine compounds | ACERTA PHARMA B.V. (NL) | 2026-05-05 | — | — | US | disclosed |
| EP-4727924-A1 | INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION | ONO Pharmaceutical Co., Ltd. (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4713319-A1 | SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-03-25 | — | — | EP | disclosed |
| EP-1124822-A4 | THROMBIN INHIBITORS | MERCK & CO INC (US) | 2002-04-03 | — | — | EP | disclosed |
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | ABBOTT LABORATORIES | 2002-02-14 | — | — | US | disclosed |
| WO-2001081316-A2 | SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2001-11-01 | — | — | WO | disclosed |
| EP-1124822-A1 | THROMBIN INHIBITORS | Merck & Co., Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| EP-1097158-A2 | LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000026211-A1 | THROMBIN INHIBITORS | MERCK & CO., INC. (US) | 2000-05-11 | — | — | WO | disclosed |
| WO-2000002887-A2 | LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630566-B2 | KRas G12D inhibitors | KRAS, NRAS, HRAS | GABRA1 3509/4885GABRB2 4258/4885GABRG2 2998/4885 |
| US-12616682-B2 | 1-H-pyrrolo[2,3-c]pyridine compounds | MEN1, PKD1, PKD2 | GABRA1 2298/4885GABRB2 1892/4885GABRG2 3350/4885 |
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | FNTA, FNTB, SLC10A1 | GABRA1 1921/4885GABRB2 2401/4885GABRG2 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.